---
title: "GNI GROUP LTD. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/16159288-86ff-5fdf-abe1-e383f80a7e83
json: https://whiteintel.dev/api/public/dossier/16159288-86ff-5fdf-abe1-e383f80a7e83
identifier: sec:0001958461
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GNI GROUP LTD.

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001958461`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/16159288-86ff-5fdf-abe1-e383f80a7e83  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/16159288-86ff-5fdf-abe1-e383f80a7e83  

## Ownership & control

### Holdings / subsidiaries

- **GYRE THERAPEUTICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/7dfebd22-337b-5e27-94f0-3c78e5f6b0fe

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GNI GROUP LTD.**. Human view: https://whiteintel.dev/entity/16159288-86ff-5fdf-abe1-e383f80a7e83 · Structured JSON: https://whiteintel.dev/api/public/dossier/16159288-86ff-5fdf-abe1-e383f80a7e83._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._